Drug Development, Groups and Health IT

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

JANUARY 8, 2024

As we kick off 2024, we wanted to start the new year with a series of 2024 Health IT predictions. We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes.

Health IT

Health IT Drug Development Pharmaceuticals BioTech

Patients and Industry: Starting Our New Life Together in 2023

Society for Participatory Medicine

FEBRUARY 1, 2023

The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. By the power vested in clinical research, the FDA now pronounces us patient and industry. You may now kiss the cancer survivor.

BioTech

BioTech Drug Development Meaningful Use Pharmaceuticals

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Lloyd Price

NOVEMBER 21, 2023

Engage with Stakeholders: Actively engage with NHS staff, patients, and advocacy groups to understand their concerns and address them proactively. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk Subscribe Today!

Drug Development

Drug Development Health science healthcare technology Leadership

Prognos Health Raises $23 Million

Healthcare IT Today

MAY 22, 2023

Prognos Health , the largest real-world integrated data marketplace, has announced that it has raised $23 million in growth equity co-led by Marshall Wace and Safeguard Scientifics , with participation from Cigna Ventures , Hikma Ventures , Hunt Holdings , Labcorp , Maywic , Merck Global Health Innovation Fund , and Red and Blue Ventures.

Life Science

Life Science Drug Development Health IT Healthcare IT

AngelEye Health Announces Series B Funding to Support Company’s Rapid Growth

Healthcare IT Today

NOVEMBER 14, 2022

Latest Round of Investment in the Family Engagement Technology Company Led by Bradford Whitmore and Mountain Group Partners, with Participation by SeedtoB Capital and the Rash Family Office. The Series B financing was led by Brad Whitmore and Mountain Group Partners (MGP), with participation from SeedtoB Capital and the Rash Family Office.

Life Science

Life Science HIPAA Drug Development healthcare technology

Atropos Health Announces Strategic Financing to Fund International Expansion and Support Key Channel Partnerships

Healthcare IT Today

OCTOBER 6, 2023

The funding enables Atropos Health to accelerate commercial and development opportunities outside the U.S.,

Life Science

Life Science Drug Development Pharmaceuticals Health IT

Taker-Shaper-Maker model and Future of Generative AI in Healthcare

Lloyd Price

APRIL 27, 2024

It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. But how can healthcare organisations best leverage this technology? Subscribe Today!

healthcare technology

healthcare technology Leadership Drug Development Digital Health

Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to Acquire the Company’s Digital Pathology Business

Healthcare IT Today

DECEMBER 27, 2022

Future releases of Dynamyx will also create opportunities for Fujifilm to support pharmaceutical and contract research organizations with toxicity testing data management for drug development. “A The company is headquartered in Lexington, Massachusetts. Click here for more information.

Pharmaceuticals

Pharmaceuticals Drug Development Medical Technology Healthcare IT

How Technology Can Help Us Achieve Health Equity

Healthcare IT Today

MAY 5, 2023

Technology continues to play a large role in healthcare, expediting and reducing the costs associated with the drug development process. The implementation of AI has been instrumental in significantly cutting down the drug development timeline and creating viable drug targets in a more timely and cost-efficient manner.

Drug Development

Drug Development Primary Care Remote care Patient Experience

PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization

Healthcare IT Today

NOVEMBER 7, 2023

A recent Deloitte study estimates the average cost of developing a single new drug at $2.3 This ML-driven adaptive process can significantly accelerate the clinical drug development process and increase certainty along the way, resulting in more efficient, targeted, and ultimately more successful clinical trials.

Drug Development

Drug Development BioTech Pharmaceuticals Health IT

Zephyr AI Raises $111 Million in Series A Financing

Healthcare IT Today

APRIL 25, 2024

The company is developing improved data federation tools along with various machine learning algorithms in the areas of oncology and cardiometabolic disease. The US has the highest rate of avoidable cancer and cardiometabolic-related deaths among any high-income country. “At

Drug Development

Drug Development healthcare technology Health IT Healthcare IT

A guide to connected health device and remote patient monitoring vendors

Healthcare IT News - Telehealth

MAY 6, 2020

Biofourmis’ digital therapeutics are used for RPM across three primary healthcare stakeholder groups: health systems, payers and pharmaceutical companies. Typically, the health systems and payers work together in a value-based care arrangement that involves shared risk and reward.

Connected Health

Connected Health Telehealth Pharmaceuticals EHR

Uses of AI in Healthcare – 2024 Health IT Predictions

Healthcare IT Today

JANUARY 17, 2024

As we kick off 2024, we wanted to start the new year with a series of 2024 Health IT predictions. We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes.

Health IT

Health IT Mental health Interoperability Patient Experience

Pharma – 2023 Health IT Predictions

Healthcare IT Today

JANUARY 9, 2023

As we head into 2023, we wanted to kick off the new year with a series of 2023 Health IT predictions. We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. Kimberly Powell, Vice President of Healthcare at NVIDIA.

Health IT

Health IT Pharmaceuticals Drug Development Life Science

Connected Health Pulse

Pharma IT and AI – 2024 Health IT Predictions

Patients and Industry: Starting Our New Life Together in 2023

Trending Sources

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Prognos Health Raises $23 Million

AngelEye Health Announces Series B Funding to Support Company’s Rapid Growth

Atropos Health Announces Strategic Financing to Fund International Expansion and Support Key Channel Partnerships

Taker-Shaper-Maker model and Future of Generative AI in Healthcare

Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to Acquire the Company’s Digital Pathology Business

How Technology Can Help Us Achieve Health Equity

PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization

Zephyr AI Raises $111 Million in Series A Financing

A guide to connected health device and remote patient monitoring vendors

Uses of AI in Healthcare – 2024 Health IT Predictions

Pharma – 2023 Health IT Predictions

Stay Connected